Hepatic arterial cannulation for regional chemotherapy is safe in patients with a liver metastasis volume of less than I litre
1997

Safety of Hepatic Arterial Cannulation for Chemotherapy in Liver Metastasis Patients

Sample size: 134 publication Evidence: moderate

Author Information

Author(s): D Burke, C Fordy, SA Earlam, TG Allen-Mersh

Primary Institution: Charing Cross and Westminster Medical School, Chelsea and Westminster Hospital, London, UK

Hypothesis

Is hepatic arterial cannulation safe for patients with liver metastasis volumes less than one liter?

Conclusion

Hepatic arterial cannulation is safe for patients with liver metastasis volumes under one liter, but those with larger volumes face higher risks.

Supporting Evidence

  • 90.2% of patients had successful cannulation.
  • Perioperative mortality was 5.8% overall.
  • Patients with > 1000 ml metastasis volume had a 23% mortality rate.

Takeaway

Doctors can safely give chemotherapy directly to the liver in patients with smaller tumors, but bigger tumors can make the procedure riskier.

Methodology

The study assessed colorectal liver metastasis patients undergoing hepatic arterial cannulation at laparotomy, measuring liver metastasis volume and monitoring complications.

Potential Biases

Potential bias due to the exclusion of patients with higher risk factors.

Limitations

The study did not include patients over 75 years or those with significant liver dysfunction, which may limit generalizability.

Participant Demographics

Median age of participants was 59 years, with a range of 48-67 years.

Statistical Information

P-Value

0.004

Statistical Significance

p=0.004

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication